Accumulating studies have shown that the HIF1α-VEGF pathway is activated in the progression of thyroid cancer [37,38], and PEDF could suppress tumor growth by the down-regulation of VEGF expression by inhibiting HIF1α, which showed the anti-angiogenic activity of PEDF [15–17]. Here, HIF1A is linked to neoplasm.